EUCTR2016-002077-35-ES进行中（未招募）1 期
CLINICAL TRIAL PHASE I / II, SINGLE-CENTER, HISTORICAL CONTROL, TO EVALUATE THE EFFECTIVENESS OF DONOR IL-15-STIMULATED NK CELLS POST TRANSPLANT INFUSION, IN ACUTE LEUKEMIA PATIENTS WITH POOR PROGNOSIS AND HAPLOIDENTICAL UNMANIPULATED TRANSPLANT
José Luís Díez Martín0 个研究点目标入组 20 人开始时间: 2016年9月9日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. More than 18 years old, with acute myeloid leukemia who goes to undergo haploidentical
- •2. Assesable disease by analitic, molecular or image techniques.
- •3.Comorbility Sorror Index less than 6.
- •4.Give informed consent according to the legal requirements.
- •5. Dispose of a donor without exclusion criteria.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 10
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •1. Possitive HIV serology.
- •2. Patients with an active infection or other underlying serious medical statement.
- •3. Any medical process, analytical abnormality or important psychiatric disorder, according to the investigator's opinion, that prevent the participation of the patient in the study.
- •4. Participation of any other interventional clíncal trial within 30 days of planned
- •enrollment into this study.
- •5.Women who are pregnant or breastfeeding
研究者
相似试验
进行中（未招募）
不适用
Phase I/II, Multicenter, Single-Arm Clinical Trial of Panitumumab in Combination with Cisplatin, Fluourouracil and Docetaxel (DCF) in Locally Advanced or Metastatic Cancer of the Stomach and Gastro-oesophageal junction. - N/AEUCTR2009-015758-39-GRHellenic Oncology Research Group (HORG)
招募中
不适用
A study to evaluate the safety and anti-tumor activity of SNK01 (NK Cells) administered in combination with chemotherapy or chemotherapy/cetuximab in local advanced or metastatic non-small cell lung cancer patients who failed tyrosine kinase inhibitor treatmentKCT0006109KMAX24
招募中
1 期
Clinical trial of infusion of activated NK cells for the treatment of children, adolescents and young adults with sarcomas.SarcomasCTIS2024-513431-25-00Hospital Universitario La Paz10
进行中（未招募）
1 期
Infusion of activated NK cells for the treatment of children, adolescents and young adults with sarcomas.SarcomaEUCTR2016-003578-42-ESAntonio Pérez-Martínez10
进行中（未招募）
1 期
PHASE II CLINICAL TRIAL, SINGLE-BLIND, RANDOMIZED, PLACEBO CONTROLLED TO EXPLORE THE EFFECTIVENESS AND SAFETY OF MELATONIN IN PATIENTS WITH COVID-19 ENTERED INTO THE INTENSIVE CARE UNITCOVID-19 infectionMedDRA version: 23.0Level: PTClassification code 10084268Term: COVID-19System Organ Class: 10021881 - Infections and infestationsEUCTR2020-001808-42-ESPharmamel S.L.18